MMWR Weekly - November 20, 1992 / 41(46);879
Centers for Disease Control and Prevention

On December 1, 1992, CDC will initiate a new, long-term, primary prevention program for human immunodeficiency virus (HIV) education. This program, "Business Responds to AIDS" (BRTA), will encourage business executives, managers, and labor leaders to undertake comprehensive workplace HIV education that includes developing written HIV policies; providing employee education; supporting education efforts for employees' families; developing manager, labor-leader, and supervisor training about companies' HIV policies and education programs; and providing corporate support and encouraging employees to provide volunteer support for community HIV-prevention activities. BRTA will help CDC in increasing public understanding of, involvement in, and support for HIV prevention.

An interactive satellite teleconference originating at CDC headquarters in Atlanta will introduce the BRTA program to the nation. Participants in the teleconference will include the American Red Cross, the U.S. Department of Health and Human Services, the New England Corporate Consortium on AIDS, and the business and labor communities from several sites throughout the United States.

To assist business and labor in initiating their own HIV-education programs, the CDC National AIDS Clearinghouse has established the BRTA Resource Service. The BRTA Resource Service has available the BRTA manager's kit, which includes materials for policy development, education program development, and additional resources. The manager's kit (cost: $25 per kit) can be obtained from the Business Responds to AIDS Resource Service, P.O. Box 6003, Rockville, MD 20849-6003.

Disclaimer   All MMWR HTML versions of articles are electronic conversions from ASCII text into HTML. This conversion may have resulted in character translation or format errors in the HTML version. Users should not rely on this HTML document, but are referred to the electronic PDF version and/or the original MMWR paper copy for the official text, figures, and tables. An original paper copy of this issue can be obtained from the Superintendent of Documents, U.S. Government Printing Office (GPO), Washington, DC 20402-9371; telephone: (202) 512-1800. Contact GPO for current prices.

921120
MM4146-879

All material in the MMWR Series is in the public domain and may be used and reprinted without special permission; citation as to source, however, is appreciated.

AEGiS is made possible through unrestricted grants from Boehringer Ingelheim, iMetrikus, Inc., the National Library of Medicine, and donations from users like you. Always watch for outdated information. This article first appeared in 1992. This material is designed to support, not replace, the relationship that exists between you and your doctor.

AEGiS presents published material, reprinted with permission and neither endorses nor opposes any material. All information contained on this website, including information relating to health conditions, products, and treatments, is for informational purposes only. It is often presented in summary or aggregate form. It is not meant to be a substitute for the advice provided by your own physician or other medical professionals. Always discuss treatment options with a doctor who specializes in treating HIV.

Copyright ©1980, 2002. AEGiS. All materials appearing on AEGiS are protected by copyright as a collective work or compilation under U.S. copyright and other laws and are the property of AEGiS, or the party credited as the provider of the content.